Key stats
About Portfolio Building Block World Pharma and Biotech Index ETF
Home page
Inception date
Nov 24, 2025
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Tidal Investments LLC
Distributor
Foreside Fund Services LLC
Identifiers
2
ISIN:US88635A2042
PBPH is passively managed, providing targeted exposure to pure-play companies in the pharmaceutical and/or biotechnology industries from the developed markets. The fund follows BITAs thematic methodology, selecting companies that derive at least 50% of their revenue from healthcare-related discovery, development, and therapeutics. Eligible securities must operate within one or more core healthcare sub-themes, including precision medicine & genetic diagnostics, pharmaceutical research & manufacturing, and biotechnology-based therapeutics. The portfolio typically holds 5080 constituents, weighted by free-float market capitalization. The index is reconstituted and rebalanced quarterly.
Related funds
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Top 10 holdings
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
PBPH trades at 24.57 USD today, its price has fallen −1.91% in the past 24 hours. Track more dynamics on PBPH price chart.
PBPH assets under management is 977.20 K USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
PBPH fund flows account for 0.00 USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
PBPH invests in stocks. See more details in our Analysis section.
PBPH expense ratio is 0.13%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, PBPH isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
No, PBPH doesn't pay dividends to its holders.
PBPH trades at a premium (0.42%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
PBPH shares are issued by Toroso Investments Topco LLC
PBPH follows the BITA Global Pharma and Biotech Select Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Nov 24, 2025.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.